MHRA approves dupilumab for treatment of uncontrolled COPD

The regulator has granted marketing authorisation for a subcutaneous injection as an add-on maintenance treatment for adults with uncontrolled COPD.
Older man wearing nebuliser

The Medicines and Healthcare products Agency (MHRA) has authorised the use of a new drug for the treatment of uncontrolled COPD.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated